SAN DIEGO – With one lawsuit by Abbvie Inc. settled out of court and another by Intermune Inc. pending, the skirmish over what's been hailed as a new era of clinical trial transparency in Europe seems likely to heat up more, as a centrally located database will make available results to just about anyone who asks, said Alexander Ehlers, an attorney with Ehlers Ehlers & Partner in Munich.